Oxipit and AstraZeneca join forces to aid early lung cancer detection


Oxipit and AstraZeneca have collaborated to do a joint pilot study, where Oxipit’s ChestEye Quality AI software is employed for improved pulmonary nodule detection.

Source

Start typing and press Enter to search